Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells

H J Song, Alan Arthur Sneddon, P A Barker, Charles Bestwick, S N Choe, S McClinton, I Grant, D Rotondo, Steven Darryll Heys, K W J Wahle

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Prostate cancer is the second most common cancer in men. The disease etiology is poorly understood, but diet and lifestyle are contributory factors. Conjugated linoleic acids (CLAs), naturally occurring fatty acids in ruminant food products, have antitumor properties in animal models of cancer and antiproliferative effects on cancer cells in vitro. The cellular mechanisms by which CLAs elicit these effects are unclear, particularly for prostate cancer cells. We have previously identified protein kinase C (PKC) isoforms alpha, delta, iota, mu, and zeta in LNCaP prostate cancer cells. The objective of this study was to determine the effects of CLAs (individual cis-9, trans-11 and trans-10, cis-12 isoforms and a 50:50 mixture) on PKC isoform abundance in LNCaP cells. Confluent cells were treated with 6,25, and 50muM CLA for 0.5, 6, and 24 h. Cytosol and membrane protein fractions were assayed for PKC isoforms (mainly alpha and delta but also iota, mu, and zeta) by Western blot analysis using specific antibodies. CLAs clearly modulated the abundance of these PKC isoforms, both positively and negatively, depending on the isoform, concentration of CLAs, and period of treatment. Increased PKC-delta and decreased PKC-iota membrane abundance was consistent with CLAs eliciting increased apoptosis and, in part, with their antitumor effects.

Original languageEnglish
Pages (from-to)100-108
Number of pages9
JournalNutrition and Cancer
Volume49
DOIs
Publication statusPublished - 2004

Keywords

  • biologically active isomers
  • signal transduction
  • Phorbol ester
  • proteolytic cleavage
  • carcinoma cells
  • PKC Delta
  • apoptosis
  • activation
  • Alpha
  • involvement

Cite this

Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells. / Song, H J ; Sneddon, Alan Arthur; Barker, P A ; Bestwick, Charles; Choe, S N ; McClinton, S ; Grant, I ; Rotondo, D ; Heys, Steven Darryll; Wahle, K W J .

In: Nutrition and Cancer, Vol. 49, 2004, p. 100-108.

Research output: Contribution to journalArticle

Song, H J ; Sneddon, Alan Arthur ; Barker, P A ; Bestwick, Charles ; Choe, S N ; McClinton, S ; Grant, I ; Rotondo, D ; Heys, Steven Darryll ; Wahle, K W J . / Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells. In: Nutrition and Cancer. 2004 ; Vol. 49. pp. 100-108.
@article{779dfa83a3734f878acb845ec857a790,
title = "Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells",
abstract = "Prostate cancer is the second most common cancer in men. The disease etiology is poorly understood, but diet and lifestyle are contributory factors. Conjugated linoleic acids (CLAs), naturally occurring fatty acids in ruminant food products, have antitumor properties in animal models of cancer and antiproliferative effects on cancer cells in vitro. The cellular mechanisms by which CLAs elicit these effects are unclear, particularly for prostate cancer cells. We have previously identified protein kinase C (PKC) isoforms alpha, delta, iota, mu, and zeta in LNCaP prostate cancer cells. The objective of this study was to determine the effects of CLAs (individual cis-9, trans-11 and trans-10, cis-12 isoforms and a 50:50 mixture) on PKC isoform abundance in LNCaP cells. Confluent cells were treated with 6,25, and 50muM CLA for 0.5, 6, and 24 h. Cytosol and membrane protein fractions were assayed for PKC isoforms (mainly alpha and delta but also iota, mu, and zeta) by Western blot analysis using specific antibodies. CLAs clearly modulated the abundance of these PKC isoforms, both positively and negatively, depending on the isoform, concentration of CLAs, and period of treatment. Increased PKC-delta and decreased PKC-iota membrane abundance was consistent with CLAs eliciting increased apoptosis and, in part, with their antitumor effects.",
keywords = "biologically active isomers, signal transduction, Phorbol ester, proteolytic cleavage, carcinoma cells, PKC Delta, apoptosis, activation, Alpha, involvement",
author = "Song, {H J} and Sneddon, {Alan Arthur} and Barker, {P A} and Charles Bestwick and Choe, {S N} and S McClinton and I Grant and D Rotondo and Heys, {Steven Darryll} and Wahle, {K W J}",
year = "2004",
doi = "10.1207/s15327914nc4901_14",
language = "English",
volume = "49",
pages = "100--108",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",

}

TY - JOUR

T1 - Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells

AU - Song, H J

AU - Sneddon, Alan Arthur

AU - Barker, P A

AU - Bestwick, Charles

AU - Choe, S N

AU - McClinton, S

AU - Grant, I

AU - Rotondo, D

AU - Heys, Steven Darryll

AU - Wahle, K W J

PY - 2004

Y1 - 2004

N2 - Prostate cancer is the second most common cancer in men. The disease etiology is poorly understood, but diet and lifestyle are contributory factors. Conjugated linoleic acids (CLAs), naturally occurring fatty acids in ruminant food products, have antitumor properties in animal models of cancer and antiproliferative effects on cancer cells in vitro. The cellular mechanisms by which CLAs elicit these effects are unclear, particularly for prostate cancer cells. We have previously identified protein kinase C (PKC) isoforms alpha, delta, iota, mu, and zeta in LNCaP prostate cancer cells. The objective of this study was to determine the effects of CLAs (individual cis-9, trans-11 and trans-10, cis-12 isoforms and a 50:50 mixture) on PKC isoform abundance in LNCaP cells. Confluent cells were treated with 6,25, and 50muM CLA for 0.5, 6, and 24 h. Cytosol and membrane protein fractions were assayed for PKC isoforms (mainly alpha and delta but also iota, mu, and zeta) by Western blot analysis using specific antibodies. CLAs clearly modulated the abundance of these PKC isoforms, both positively and negatively, depending on the isoform, concentration of CLAs, and period of treatment. Increased PKC-delta and decreased PKC-iota membrane abundance was consistent with CLAs eliciting increased apoptosis and, in part, with their antitumor effects.

AB - Prostate cancer is the second most common cancer in men. The disease etiology is poorly understood, but diet and lifestyle are contributory factors. Conjugated linoleic acids (CLAs), naturally occurring fatty acids in ruminant food products, have antitumor properties in animal models of cancer and antiproliferative effects on cancer cells in vitro. The cellular mechanisms by which CLAs elicit these effects are unclear, particularly for prostate cancer cells. We have previously identified protein kinase C (PKC) isoforms alpha, delta, iota, mu, and zeta in LNCaP prostate cancer cells. The objective of this study was to determine the effects of CLAs (individual cis-9, trans-11 and trans-10, cis-12 isoforms and a 50:50 mixture) on PKC isoform abundance in LNCaP cells. Confluent cells were treated with 6,25, and 50muM CLA for 0.5, 6, and 24 h. Cytosol and membrane protein fractions were assayed for PKC isoforms (mainly alpha and delta but also iota, mu, and zeta) by Western blot analysis using specific antibodies. CLAs clearly modulated the abundance of these PKC isoforms, both positively and negatively, depending on the isoform, concentration of CLAs, and period of treatment. Increased PKC-delta and decreased PKC-iota membrane abundance was consistent with CLAs eliciting increased apoptosis and, in part, with their antitumor effects.

KW - biologically active isomers

KW - signal transduction

KW - Phorbol ester

KW - proteolytic cleavage

KW - carcinoma cells

KW - PKC Delta

KW - apoptosis

KW - activation

KW - Alpha

KW - involvement

U2 - 10.1207/s15327914nc4901_14

DO - 10.1207/s15327914nc4901_14

M3 - Article

VL - 49

SP - 100

EP - 108

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

ER -